Organisation
Department of Cardiovascular Sciences
Department
For more information about the research topics of the different research teams belonging to this department see: - Division for Cardiology - Division for Hypertension and Cardiovascular Revalidation - Division for Cardiovascular Developmental Physiology - Division for Molecular and Vascular Biology
The Department of Cardiovascular Sciences aims to increase knowledge in cardiovascular biology and diseases, to implement translation from bench to bedside and to improve patient care and cardiovascular health.
Sub-organisation(s)
1 - 10 of 12
Current researchers
1 - 4 of 4 results
- Werner Budts (Responsible)
- Alejandro Frangi (Member)
- Paul Holvoet (Member)
- Marcus Ingram (Member)
Projects
1 - 10 of 27
- Urinary PROteomics in Predicting HEart Transplantation outcomesFrom1 Oct 2016 → 31 Mar 2018Funding: H2020 - Frontier Research (ERC)
- Analysing and Modulating Apoptosis Sensitisation and Resistance in Cultured and Patient-Derived Cardiac Cells by Quantitative Biochemistry and Computational Systems Biology Implications to Cardiotoxicity and Differentiation.From1 Oct 2015 → 30 Sep 2016Funding: BOF - Concerted Research Project from 1994
- Do shared “omics” biomarkers reveal a systemic pathogenetic condition explaining association between left ventricular dysfunction and macrovascular disease?From4 May 2015 → 10 Dec 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Quantitative approach to assess function and apoptosis changes in the H9C2 cardiomyocyte cell line following differentiation and Doxorubicin exposureFrom1 Dec 2014 → 8 Aug 2019Funding: BOF - doctoral mandates, BOF - Doctoral projects
- Role of Matrix Gla Protein and the Microcirculation in Differentiating Health from DiseaseFrom14 Nov 2014 → 26 Oct 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Adverse health outcomes in relation to blood pressure and genetic, epigenetic and environmental risk factorsFrom1 Oct 2014 → 26 Oct 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- "-omics" as tool to address the burden of non-communicable age-related disease in populations in epidemiological transitionFrom15 Mar 2014 → 15 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Heart OMics in AGEing: the prevalence of heart failure (HF).From19 Nov 2013 → 31 Jan 2019Funding: General Activities (Annex IV)
- Genetic and mtDNA contributions to early cardiovascular ageing and disease: a population studyFrom1 Oct 2013 → 28 Jun 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Regulation of endocardial cell plasticity during embryonic heart valve development and maturation through BMP SMADFrom1 Sep 2013 → 30 Sep 2018Funding: FWO fellowships
Publications
41 - 50 of 884
- Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF(2021)
Authors: Jan A Staessen, Stephane Heymans
Pages: 268 - 277 - RENAL NERVE STIMULATION INDUCED BLOOD PRESSURE CHANGES ARE STRONGLY CORRELATED WITH RENAL DENERVATION INDUCED CHANGES IN 24-HOUR BLOOD PRESSURE DURING FOLLOW-UP(2016)
Authors: Arif Elvan, Mark de Jong, Ahmet Adiyaman, Pim Gal, Jaap Jan Smit, Peter Delnoy, Jan-Evert Heeg, Boudewijn van Hasselt, Elizabeth Lau, Alexandre Persu, et al.
Pages: 2270 - 2270 - Systolic and diastolic left ventricular dysfunction: from risk factors to overt heart failure(2010)
Authors: Tatiana Kouznetsova, Lieven Herbots, Yu Jin, Jan A Staessen
Pages: 251 - 8 - PROGNOSTIC VALUE OF 24-H BLOOD PRESSURE VARIABILITY IN 7040 SUBJECTS FROM 6 POPULATIONS(2009)
Authors: TW Hansen, L Thijs, J Boggia, Y Li, M Kikuya, K Bjorklund-Bodegard, Tom Richart, T Ohkubo, J Jeppesen, C Torp Pedersen, et al.
Pages: S51 - S51 - Is blood pressure during the night more predictive of Cardiovascular Outcome than during the day?(2008)
Authors: Y Li, J Boggia, Lutgarde Thijs, TW Hansen, M Kikuya, K Björklund-Bodegård, T Richart, T Ohkubo, T Kuznetsova, C Torp-Pedersen, et al.
Pages: 145 - 147 - Vermindering van de zoutinname: van een bevolkingsoverkoepelende naar een gepersonaliseerde benadering. Een reactie van professor Jan A. Staesen(2016)
Authors: Jan A Staessen
Pages: 224 - 224 - SAH gene variants revisited in the European Project on Genes in Hypertension(2008)
Authors: Jan A Staessen, Tatiana Kouznetsova, Lutgarde Thijs
Pages: 244 - 250 - The -665 C>T polymorphism in the eNOS gene predicts cardiovascular mortality and morbidity in white Europeans(2015)
Authors: Lutgarde Thijs, Yu Jin, Thibault Petit, Tatiana Kouznetsova, Jan A Staessen
Pages: 167 - 72 - Persistence of Beneficial Effects of Cardiovascular Preventive Pharmacotherapy After Discontinuation of Blinded Therapy(2009)
Authors: William J Kostis, John B Kostis, Jan A Staessen
Pages: A381 - A381 - First-in-Man Randomized Clinical Trial of Renal Denervation for Atrial Arrhythmia Raises Concern(2013)
Authors: Jan A Staessen, Lutgarde Thijs
Pages: E445 - E446